Onconetix (ONCO) Profit After Tax (2021 - 2026)

Onconetix (ONCO) has reported Profit After Tax for 6 consecutive years, with -$4.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax rose 48.22% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$7.1 million (up 87.07% YoY), while the FY2025 annual figure was -$11.2 million, up 80.92% from the prior year.
• Profit After Tax eased to -$4.4 million in Q1 2026 per ONCO's latest filing, from $8.5 million in the prior quarter.
• Across five years, Profit After Tax topped out at $8.5 million in Q4 2025 and bottomed at -$28.1 million in Q4 2024.
• Historically, Profit After Tax has averaged -$7.1 million across 5 years, with a median of -$4.4 million in 2026.
• Annual changes were most pronounced in 2022 — Profit After Tax sank 535.6% — and 2025, when it jumped 130.3%.
• Onconetix's Profit After Tax stood at -$3.2 million in 2022, then plunged by 520.58% to -$20.0 million in 2023, then slumped by 40.56% to -$28.1 million in 2024, then surged by 130.3% to $8.5 million in 2025, then plunged by 152.04% to -$4.4 million in 2026.
• Business Quant data shows ONCO's Profit After Tax at -$4.4 million in Q1 2026, $8.5 million in Q4 2025, and -$8.8 million in Q3 2025.